REGISTERED
on 19 Nov 2019
Last Applicant/ Owned by
11111 SANTA MONICA BLVD STE 1700
LOS ANGELES
CA
90025
Serial Number
88317134 filed on 26th Feb 2019
Registration Number
5916753 registered on 19th Nov 2019
Correspondent Address
Britt L. Anderson
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
NAMMI THERAPEUTICS
Pharmaceutical preparations for use in immunotherapy; tumor suppressing agents; pharmaceutical products for the treatment of cancer and tumors; pharmaceuticals, namely, immunogenic cell death inducers; therapeutic agents for promotion of cancer immunity
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in immunotherapy; tumor suppressing agents; pharmaceutical products for the treatment of cancer and tumors; pharmaceuticals, namely, immunogenic cell death inducers; therapeutic agents for promotion of cancer immunity
First Use Date in General
16th Sep 2019
First Use Date in Commerce
16th Sep 2019
Mark Details
Serial Number
No 88317134
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 131208.4000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Nov 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 31st Mar 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 03rd Mar 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 19th Nov 2019 | REGISTERED-PRINCIPAL REGISTER |
| 12th Oct 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 11th Oct 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 07th Oct 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| 07th Oct 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 17th Sep 2019 | USE AMENDMENT FILED |
| 17th Sep 2019 | TEAS STATEMENT OF USE RECEIVED |